Alexander Hall-Daniels

Alexander Hall-Daniels is a prominent figure in the biotechnology and venture capital sectors, currently serving as a Principal at SOSV, specifically within the IndieBio program in New York. His career at SOSV began in 2018 when he joined the London-based life science program, RebelBio, before transitioning to his current role at IndieBio, which focuses on early-stage biotech startups.1

Educational Background

Hall-Daniels holds a Bachelor of Science (BSc) degree in Biochemistry, Biophysics, and Molecular Biology from Imperial College London. He also completed a Joint Honours degree in Business Management from Imperial Business School, equipping him with a unique blend of scientific and business acumen that he applies in his venture capital work.12

Professional Experience

Before joining SOSV, Hall-Daniels gained valuable experience in various roles:

• Program Associate at RebelBio
• Account Executive at Edelman London, where he worked with major pharmaceutical companies such as GlaxoSmithKline and Pfizer.12

His diverse background encompasses not only venture capital but also entrepreneurship and consultancy, having started his career at a boutique business consultancy in Philadelphia.1 This multifaceted experience allows him to effectively support and guide biotech startups through their developmental phases.

Contributions to the Industry

At IndieBio, Hall-Daniels is actively involved in fostering innovation within the biotech sector. He emphasizes the importance of experimentation and iteration in developing solutions to critical societal challenges, particularly those related to human and planetary health.3 His role involves mentoring founders and helping them navigate the complexities of launching and scaling their ventures.

In summary, Alexander Hall-Daniels is an influential leader in the biotech investment community, leveraging his educational background and professional experiences to drive innovation and support emerging companies within the industry.